Financhill
Back

Biosyent Stock Predictions

Biosyent Stock Forecast

  • Over the next 52 weeks, Biosyent has on average historically risen by 54.2% based on the past 27 years of stock performance.
  • Biosyent has risen higher in 13 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.15%
  • Is Biosyent Stock Undervalued?
    The current Biosyent [RX.V] share price is $11.9800. The Score for RX.V is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • RX.V is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Biosyent Stock Go Up Next Year?

  • Over the next 52 weeks, Biosyent has on average historically risen by 54.2% based on the past 27 years of stock performance.

Biosyent Stock Rating

Buy
62
Biosyent (RX.V) is a Buy

Is Biosyent overpriced?

  • Biosyent has risen higher in 13 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.15%

Biosyent Stock Price History

Is RX.V stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RX.V is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
TSXV
Country:
Canada
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
biosyent.com

52-Week Data

52-Week High:
11.7400
52-Week Low:
8.2400

Prediction Charts

Market Cap:
138.9M
Price in USD:
11.9800
Volume:
1.51K
Beta:
1.1327

Technical Analysis

SMA50:
11.2110
SMA100:
10.8390
SMA200:
9.9515
52-Wk Change:
36.91%

Stock Predictions

  • Is Biosyent stock public?
    Yes, Biosyent is a publicly traded company.
  • What is the Biosyent stock quote today?
    The Biosyent stock price is 11.9800 USD today.
  • How to buy Biosyent stock online?
    You can buy Biosyent shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-26 11.5200 11.5200 11.5200 11.5200
Nov-27 11.3000 11.5100 11.5100 11.1200
Nov-28 11.3900 11.3800 11.3900 11.3800
Nov-29 11.2900 11.2600 11.2900 11.2600
Dec-2 11.2600 11.3500 11.3700 11.2600
Dec-3 11.1200 11.3300 11.3300 11.1100
Dec-4 11.1100 11.2500 11.2500 11.0600
Dec-5 11.2500 11.0000 11.2900 11.0000
Dec-6 11.2800 11.3500 11.3500 11.2400
Dec-9 11.4800 11.6500 11.6500 11.3900
Dec-10 11.4500 11.6300 11.6300 11.4500
Dec-11 11.4700 11.7000 11.7000 11.4700
Dec-12 11.5700 11.6100 11.6100 11.5700
Dec-13 11.3200 11.9800 11.9800 11.3200

Biosyent Earnings

Biosyent Earnings Report: Per Share Biosyent Earnings Q1 Q2 Q3 and Q4 last year and next year.

Biosyent Forecast Revenue Growth

Biosyent Stock Analysis: Historical quarterly revenues per share for Biosyent and historical quarterly revenue growth:

* Biosyent stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.